Okogen

Encinitas, United States

Okogen is a developer of ophthalmic anti-infective drugs.

$3.3M raised

Dec 2024

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Okogen raised?

Okogen has raised $3.3M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.

Who are Okogen's investors?

Okogen's investors include Brandon Capital, Medical Research Commercialisation Fund (MRCF).

Where is Okogen headquartered?

Okogen is headquartered in Encinitas, United States.

What does Okogen do?

Okogen is a developer of ophthalmic anti-infective drugs.

What stage is Okogen at?

Okogen is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 11, 2024.

MLA

"Okogen — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/okogen. Accessed July 2, 2026.

APA

VCBacked. (2024). Okogen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/okogen

Wikipedia (cite web)

{{cite web |title=Okogen — Funding & Investors |url=https://www.vcbacked.co/company/okogen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 11, 2024.